Spots Global Cancer Trial Database for gene transfer
Every month we try and update this database with for gene transfer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning | NCT00664196 | Prostate Cancer | Gene Modified T... | 18 Years - | Roger Williams Medical Center | |
| Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer | NCT00372320 | Parotid Salivar... | Gene Transfer AdhAQP1 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer | NCT00372320 | Parotid Salivar... | Gene Transfer AdhAQP1 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Intrapleural Gene Transfer for Pleural Mesothelioma | NCT01212367 | Malignant Pleur... | SCH 721015 SCH 721015 | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer | NCT00429078 | Gastric Cancer | 2nd Generation ... | 18 Years - | Roger Williams Medical Center | |
| Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer | NCT00121745 | Pancreatic Canc... | Rexin-G Dose 1 Rexin-G Dose 2 Rexin-G Dose 3 Rexin-G Dose 4 | 18 Years - | Epeius Biotechnologies | |
| Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies | NCT00427726 | Gene Transfer | - | National Institutes of Health Clinical Center (CC) | ||
| Gene Therapy for the Treatment of Brain Tumors | NCT00001328 | Brain Neoplasm Neoplasm Metast... | Cytovene (Ganci... G1TKSVNa.53 Pro... | 19 Years - | National Institutes of Health Clinical Center (CC) | |
| Trial of Second Generation Designer T Cells in Colorectal Carcinoma | NCT00673322 | Colorectal Canc... | Gene Modified T... | 18 Years - | Roger Williams Medical Center | |
| Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas | NCT01723306 | Metastatic Canc... | Gene Modified T... | 18 Years - 80 Years | Roger Williams Medical Center | |
| Phase II Trial of Allovectin-7® for Metastatic Melanoma | NCT00044356 | Melanoma Metastatic Mela... Malignant Melan... Skin Cancer | Allovectin-7® | 18 Years - | Vical | |
| Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning | NCT00664196 | Prostate Cancer | Gene Modified T... | 18 Years - | Roger Williams Medical Center | |
| Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer | NCT00059605 | Lung Cancer | DOTAP:Chol-fus1 | - | M.D. Anderson Cancer Center | |
| Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver | NCT00035919 | Colorectal Neop... | Mx-dnG1 Retrovi... | 18 Years - | University of Southern California | |
| Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies | NCT04266093 | Cervical Intrae... Cervical Neopla... Oropharyngeal N... Squamous Intrae... Hematologic Mal... | GeneTherapy | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer | NCT00673829 | Breast Cancer | Gene Modified T... Gene Modified T... | 18 Years - | Roger Williams Medical Center | |
| A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma | NCT00289016 | Melanoma | Talimogene Lahe... | 18 Years - | BioVex Limited | |
| Trial of Second Generation Designer T Cells in Colorectal Carcinoma | NCT00673322 | Colorectal Canc... | Gene Modified T... | 18 Years - | Roger Williams Medical Center | |
| Gene Therapy for the Treatment of Brain Tumors | NCT00001328 | Brain Neoplasm Neoplasm Metast... | Cytovene (Ganci... G1TKSVNa.53 Pro... | 19 Years - | National Institutes of Health Clinical Center (CC) | |
| Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer | NCT00673829 | Breast Cancer | Gene Modified T... Gene Modified T... | 18 Years - | Roger Williams Medical Center | |
| Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas | NCT01723306 | Metastatic Canc... | Gene Modified T... | 18 Years - 80 Years | Roger Williams Medical Center | |
| Trial of Second Generation Designer T Cells in Colorectal Carcinoma | NCT00673322 | Colorectal Canc... | Gene Modified T... | 18 Years - | Roger Williams Medical Center | |
| Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma | NCT00323206 | Malignant Melan... | IL-12p DNA Intratumoral El... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma | NCT00323206 | Malignant Melan... | IL-12p DNA Intratumoral El... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
